Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders : an exploratory study. / Abdallah, Morsi; Pearce, Brad D; Larsen, Nanna ; Greaves-Lord, Kirstin; Nørgaard-Pedersen, Bent; Hougaard, David M; Mortensen, Erik L; Grove, Jakob.
In: Autism Research, Vol. 5, No. 6, 12.2012, p. 428-33.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders
T2 - an exploratory study
AU - Abdallah, Morsi
AU - Pearce, Brad D
AU - Larsen, Nanna
AU - Greaves-Lord, Kirstin
AU - Nørgaard-Pedersen, Bent
AU - Hougaard, David M
AU - Mortensen, Erik L
AU - Grove, Jakob
N1 - © 2012 International Society for Autism Research, Wiley Periodicals, Inc.
PY - 2012/12
Y1 - 2012/12
N2 - Evidence suggests that some developmental disorders, such as autism spectrum disorders (ASDs), are caused by errors in brain plasticity. Given the important role of matrix metalloproteinases (MMPs) and neurotrophins (NTs) in neuroplasticity, amniotic fluid samples for 331 ASD cases and 698 frequency-matched controls were analyzed for levels of MMP-9, brain-derived neurotrophic factor, NT-4 and transforming growth factor-ß utilizing a Danish historic birth cohort and Danish nationwide health registers. Laboratory measurements were performed using an in-house multiplex sandwich immunoassay Luminex xMAP method, and measurements were analyzed using tobit and logistic regression. Results showed elevated levels of MMP-9 in ASD cases compared with controls (crude and adjusted tobit regression P-values: 0.01 and 0.06). Our results highlight the importance of exploring the biologic impact of MMP-9 and potential therapeutic roles of its inhibitors in ASD and may indicate that neuroplastic impairments in ASD may present during pregnancy.
AB - Evidence suggests that some developmental disorders, such as autism spectrum disorders (ASDs), are caused by errors in brain plasticity. Given the important role of matrix metalloproteinases (MMPs) and neurotrophins (NTs) in neuroplasticity, amniotic fluid samples for 331 ASD cases and 698 frequency-matched controls were analyzed for levels of MMP-9, brain-derived neurotrophic factor, NT-4 and transforming growth factor-ß utilizing a Danish historic birth cohort and Danish nationwide health registers. Laboratory measurements were performed using an in-house multiplex sandwich immunoassay Luminex xMAP method, and measurements were analyzed using tobit and logistic regression. Results showed elevated levels of MMP-9 in ASD cases compared with controls (crude and adjusted tobit regression P-values: 0.01 and 0.06). Our results highlight the importance of exploring the biologic impact of MMP-9 and potential therapeutic roles of its inhibitors in ASD and may indicate that neuroplastic impairments in ASD may present during pregnancy.
U2 - 10.1002/aur.1254
DO - 10.1002/aur.1254
M3 - Journal article
C2 - 23008271
VL - 5
SP - 428
EP - 433
JO - Autism Research
JF - Autism Research
SN - 1939-3792
IS - 6
ER -
ID: 44583147